Protalix Restates Stock Incentive Plan
Protalix BioTherapeutics filed an 8-K to amend and restate its 2006 Stock Incentive Plan, effective June 25, 2026, to provide updated rewards for employees and directors.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day